The ALN undecapeptide

The ALN BMS202 undecapeptide buy BI 10773 is most similar to that of PLO (Figure 3B), in that it retains the three tryptophan residues of the consensus undecapeptide but employs an alternate spacing (i.e. WxxWW rather than WxWW). The tryptophan residues of the undecapeptide are known to be important

for insertion of domain 4 into host cell membranes [42]. Like the human-specific CDCs (VLY, ILY, and LLY), ALN contains a proline in its undecapeptide sequence. However, the hemolytic activity of ALN was not blocked by antibodies to human CD59, which acts as a receptor for the human-specific CDCs [23, 32, 33], suggesting that ALN may interact with a distinct membrane receptor, perhaps in addition to cholesterol. The nature of the ALN receptor is currently unknown and is under investigation. Although the cysteine residue in the consensus undecapeptide confers the property of thiol activation to CDCs, the cysteine is not essential for streptolysin O and pneumolysin toxin function [43, 44]. The human-specific CDCs (VLY, ILY, LLY), PLO, and ALN all lack this website this conserved cysteine residue, but the contribution of this sequence variation to toxin function is not yet known for these toxins. Some CDCs have a number of functions beyond simple pore

formation. Streptococcus pyogenes uses streptolysin O to introduce a bacterial effector into host cells via a novel mechanism termed cytolysin-mediated translocation (CMT) [45]. At sublytic concentrations, CDCs may act as ligands for toll-like receptors [46, 47] and may induce a cycle of p38 mitogen-activated protein kinase (MAPK) phosphorylation and dephosphorylation [48, 49]. LLO allows Listeria monocytogenes to escape from the vacuole into the cytoplasm where the organism can rapidly multiply [50]. The site-specific nature of LLO is controlled by cytosolic down-regulation of LLO function due to an N-terminal PEST-like sequence, which usually targets eukaryotic proteins for cytosolic degradation. The PEST sequence results in a substantially

reduced half-life of LLO in the cytoplasm of the host cell [29]. Conclusions ALN has several unique features among the CDC family. ALN has a variant undecapeptide and possesses an unusual MRIP N-terminal extension, with a putative PEST sequence. Moreover, ALN lacks the conserved cysteine of thiol-activated CDCs, explaining why β-mercaptothanol had no effect on ALN function. The unique sequences and predicted structural features of ALN will make it an interesting toxin to conduct future structure-function analyses to identify additional unique properties of this toxin. ALN displays an unusual pattern of target cell species selectivity, with high activity against human, horse, and rabbit cells and lesser activity against cells derived from other species. This selectivity appears to function at the level of membrane binding and may contribute to the host range of A. haemolyticum.

Comments are closed.